Foerster, R.; Zwahlen, D.R.; Buchali, A.; Tang, H.; Schroeder, C.; Windisch, P.; Vu, E.; Akbaba, S.; Bostel, T.; Sprave, T.;
et al. Stereotactic Body Radiotherapy for High-Risk Prostate Cancer: A Systematic Review. Cancers 2021, 13, 759.
https://doi.org/10.3390/cancers13040759
AMA Style
Foerster R, Zwahlen DR, Buchali A, Tang H, Schroeder C, Windisch P, Vu E, Akbaba S, Bostel T, Sprave T,
et al. Stereotactic Body Radiotherapy for High-Risk Prostate Cancer: A Systematic Review. Cancers. 2021; 13(4):759.
https://doi.org/10.3390/cancers13040759
Chicago/Turabian Style
Foerster, Robert, Daniel Rudolf Zwahlen, Andre Buchali, Hongjian Tang, Christina Schroeder, Paul Windisch, Erwin Vu, Sati Akbaba, Tilman Bostel, Tanja Sprave,
and et al. 2021. "Stereotactic Body Radiotherapy for High-Risk Prostate Cancer: A Systematic Review" Cancers 13, no. 4: 759.
https://doi.org/10.3390/cancers13040759
APA Style
Foerster, R., Zwahlen, D. R., Buchali, A., Tang, H., Schroeder, C., Windisch, P., Vu, E., Akbaba, S., Bostel, T., Sprave, T., Zamboglou, C., Zilli, T., Stelmes, J.-J., Telkhade, T., & Murthy, V.
(2021). Stereotactic Body Radiotherapy for High-Risk Prostate Cancer: A Systematic Review. Cancers, 13(4), 759.
https://doi.org/10.3390/cancers13040759